| Dr Douglas Bazil Tzanetos, MD | |
|
9113 Leesgate Rd, Louisville, KY 40222-5003 | |
| (502) 426-1621 | |
| (502) 426-7906 |
| Full Name | Dr Douglas Bazil Tzanetos |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 22 Years |
| Location | 9113 Leesgate Rd, Louisville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730274929 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 39285 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hardin Memorial Hospital | Elizabethtown, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Psf Pllc | 1557265543 | 98 |
| Psf Pllc | 1557265543 | 98 |
News Archive
Foundation Medicine today announced new data from a pilot study demonstrating that its fully informative genomic profile for hematologic malignancies, FoundationOne Heme, identified both novel and previously reported clinically actionable genomic alterations in multiple myeloma cases. These data were presented in an oral presentation titled Pilot Study To Evaluate The Prevalence Of Actionable Oncogenic Mutations In Patients With Relapsed Refractory Multiple Myeloma (abstract number 755) by Alexander Lesokhin, M.D., medical oncologist, Memorial Sloan-Kettering Cancer Center, at the 55th American Society of Hematology Annual Meeting in New Orleans.
Incyte Corporation (Nasdaq:INCY) announced positive clinical trial results for a topical formulation of its lead janus kinase (JAK) inhibitor, INCB18424, in psoriasis.
Considerable gap in evidence around whether portable air filters reduce the incidence of COVID-19 and other respiratory infections.
It is well known that non-cardiac chest pain is closely related to gastroesophageal reflux diseases (GERD).
› Verified 4 days ago
| Entity Name | Psf Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881785947 PECOS PAC ID: 1557265543 Enrollment ID: O20031121000240 |
News Archive
Foundation Medicine today announced new data from a pilot study demonstrating that its fully informative genomic profile for hematologic malignancies, FoundationOne Heme, identified both novel and previously reported clinically actionable genomic alterations in multiple myeloma cases. These data were presented in an oral presentation titled Pilot Study To Evaluate The Prevalence Of Actionable Oncogenic Mutations In Patients With Relapsed Refractory Multiple Myeloma (abstract number 755) by Alexander Lesokhin, M.D., medical oncologist, Memorial Sloan-Kettering Cancer Center, at the 55th American Society of Hematology Annual Meeting in New Orleans.
Incyte Corporation (Nasdaq:INCY) announced positive clinical trial results for a topical formulation of its lead janus kinase (JAK) inhibitor, INCB18424, in psoriasis.
Considerable gap in evidence around whether portable air filters reduce the incidence of COVID-19 and other respiratory infections.
It is well known that non-cardiac chest pain is closely related to gastroesophageal reflux diseases (GERD).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Douglas Bazil Tzanetos, MD 9800 Shelbyville Rd Ste 220, Louisville, KY 40223-2992 Ph: (502) 429-8585 | Dr Douglas Bazil Tzanetos, MD 9113 Leesgate Rd, Louisville, KY 40222-5003 Ph: (502) 426-1621 |
News Archive
Foundation Medicine today announced new data from a pilot study demonstrating that its fully informative genomic profile for hematologic malignancies, FoundationOne Heme, identified both novel and previously reported clinically actionable genomic alterations in multiple myeloma cases. These data were presented in an oral presentation titled Pilot Study To Evaluate The Prevalence Of Actionable Oncogenic Mutations In Patients With Relapsed Refractory Multiple Myeloma (abstract number 755) by Alexander Lesokhin, M.D., medical oncologist, Memorial Sloan-Kettering Cancer Center, at the 55th American Society of Hematology Annual Meeting in New Orleans.
Incyte Corporation (Nasdaq:INCY) announced positive clinical trial results for a topical formulation of its lead janus kinase (JAK) inhibitor, INCB18424, in psoriasis.
Considerable gap in evidence around whether portable air filters reduce the incidence of COVID-19 and other respiratory infections.
It is well known that non-cardiac chest pain is closely related to gastroesophageal reflux diseases (GERD).
› Verified 4 days ago
Dr. Derek A Damin, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 163 South English Station Road, Louisville, KY 40245 Phone: 502-882-2063 Fax: 502-882-2067 | |
David E Pallares, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 9800 Shelbyville Rd Ste 220, Louisville, KY 40223 Phone: 502-429-8585 Fax: 502-429-6157 | |
Ronald Peter Moyer, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 4402 Churchman Ave, Louisville, KY 40215 Phone: 502-361-9935 Fax: 502-361-9950 | |
Dr. Daniel P Garcia, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 9113 Leesgate Rd, Louisville, KY 40222 Phone: 502-426-1621 Fax: 502-426-7906 | |
Timothy A Feger, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 9800 Shelbyville Rd, Suite #220, Louisville, KY 40223 Phone: 502-429-8585 Fax: 502-429-6157 | |
Natalie Beaven Miller, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 9800 Shelbyville Rd, Suite #220, Louisville, KY 40223 Phone: 502-429-8585 Fax: 502-753-0889 | |
James W. Sublett, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 9800 Shelbyville Rd, Suite #220, Louisville, KY 40223 Phone: 502-429-8585 Fax: 502-429-6157 |